Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
WA
Consensus Narrative from 36 Analysts
Planned Respiratory Therapies And African Expansion Will Fuel Future Success
Key Takeaways Planned respiratory therapies and product launches could drive increased revenue and enhance the chronic therapy segment's growth. Strategic expansion in Africa and ongoing R&D investments aim to strengthen margins and sustain long-term profit growth.
View narrative₹1.63k
FV
11.5% undervalued intrinsic discount8.61%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
17 days ago author updated this narrative